| Typicality: | 0.572 |
| Saliency: | 0.374 |
| at 1 and 2 years | 5 | temporal |
| after the intervention for all participants | 3 | temporal |
| by this study's research coordinator | 2 | other |
| measure → be taken at → baseline | 12 |
| measure → be administered at → baseline | 10 |
| measure → be assessed at → baseline | 6 |
| measure → be completed at → baseline | 3 |
| negative | neutral | positive |
| 0.075 | 0.882 | 0.043 |
| Raw frequency | 31 |
| Normalized frequency | 0.374 |
| Modifier score | 1.000 |
| Perplexity | 52.927 |